C12N 5/065
Thymocytes
Official title: {Thymocytes}
C12N5/065 (Thymocytes) appears on 25 US grants and 56 published applications in this corpus.
Search patents in C12N- Granted patents
- 25
- Published applications
- 56
- Assignees
- 34
- Inventors
- 114
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 3 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 3 |
| 2017 | 2 | 2 |
| 2018 | 0 | 1 |
| 2019 | 2 | 3 |
| 2020 | 1 | 7 |
| 2021 | 1 | 4 |
| 2022 | 0 | 5 |
| 2023 | 2 | 3 |
| 2024 | 4 | 4 |
| 2025 | 2 | 7 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion7 Jul 2026US 12,673,982 B2Iovance Biotherapeutics, Inc.
- Methods of determining the suitability of cultured thymus tissue for implantation into humans and associated methods of use22 Jul 2025US 12,364,715 B2Duke University
- Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same4 Feb 2025US 12,215,349 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Thymic epithelial cells, exosomes derived therefrom, and methods of making and using same15 Oct 2024US 12,116,598 B2Loyola University of Chicago
- Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants20 Aug 2024US 12,064,452 B2Duke University
- Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion17 Sep 2026US 2026/0274920 A1Iovance Biotherapeutics, Inc.
- Methods for generating artificial thymus, products and uses thereof17 Sep 2026US 2026/0275290 A1
- Thymic cell compositions and methods of making3 Sep 2026US 2026/0256842 A1Thymmune Therapeutics, Inc.
- Injectable thymus organoids25 Jun 2026US 2026/0176586 A1Fibrobiologics, Inc.
- Process for obtaining functional lymphocytes cells18 Dec 2025US 2025/0382575 A1Institut National de la Sante et de la Recherche Medicale
Most cited
By later US patents
- T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments61US 5,766,944 A1998
- Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker47US 5,821,108 AThe Board of Trustees of the Leland Stanford Junior University · 1998
- Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion14US 10,415,015 B2Iovance Biotherapeutics, Inc. · 2019
- Retinol derivatives useful for enhancing immune response11US 5,908,868 ASloan-Kettering Institute for Cancer Research · 1999
- Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells10US 9,228,007 B1The Regents of the University of California · 2016